ELAN
Elanco Animal Health Inc
Key Financials
Net Income
$-232000000
↓ 168.6%
Gross Profit
$2.6B
↑ 6.4%
EPS (Diluted)
$-0.47
↓ 169.1%
Total Liabilities
$6.8B
↑ 4.5%
Cash & Equivalents
$545.0M
↑ 16.5%
Total Assets
$13.4B
↑ 5.9%
Revenue
$4.7B
↑ 6.2%
Shareholders' Equity
$6.5B
↑ 7.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELAN |
| Company Name | Elanco Animal Health Inc |
| CIK | 1739104 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 877-352-6261 |